Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 6, 1999, Pages 1932-1937

  Hadigan, Colleen ^b   Miller, Karen ^a   Corcoran, Colleen ^a   Anderson, Ellen ^c   Basgoz, Nesli ^d   Grinspoon, Steven ^a,e  

^a Neuroendocrine Unit   (United States)

^b Harvard Combined Program in Gastroenterologe and Nutrition   (United States)

^c Infectious Disease Unit   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LIPID; PROTEINASE INHIBITOR;

ADULT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPODYSTROPHY; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0033305699     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.6.1932     Document Type: Article

References (17)

1. 'Buffalo hump' in men with HIV-1 infection
2. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients
3. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors
4. Visceral abdominal-fat accumulation associated with use of indinavir
5. Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients
6. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: A pilot study
7. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting
8. Determinants of increased energy expenditure in HIV-infected women
9. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values
10. Lipodystrophy associated with and HIV-protease inhibitor
11. Studies of body composition and fat distribution in HIV-infected and control subjects
12. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
13. Increased de novo hepatic lipogenesis in human immunodeficiency virus infection
14. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidemia and insulin resistance